RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @cphiv: Latest ACTIV-3/TICO Study publication evaluates whether levels of plasma antigen can predict short-term clinical outcomes in hos…
Latest ACTIV-3/TICO Study publication evaluates whether levels of plasma antigen can predict short-term clinical outcomes in hospitalized patients with SARS-CoV-2. https://t.co/bfkrec8chw https://t.co/VkfFqa2Dd0
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 | Annals of Internal Medicine https://t.co/a87Xz6lDRS
ただしこの研究はDeltaまででOmicron期には行われていない. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 https://t.co/SUI7k43z06 5/5
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
https://t.co/OQpunIfUYI 日本で血中抗原測ってる施設ってあるんかな?
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. https://t.co/DpQkS9Px0L
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @shuichiotsu: ・Annals of Internal Medicine https://t.co/8PvhVdAfXP
・Annals of Internal Medicine https://t.co/8PvhVdAfXP
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @KusumiEiji: 血清中のコロナウイルス抗原量(ウイルス量の代替指標)が多いほど、症状が重い https://t.co/zb66GSRGeX
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @MamtaKJain: Excited to see our paper published. Important observation of Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
@ACRRM @RuralDoctorsAus @QldRGP @RVTSgpTRAINING @OchreHealth
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
'High plasma viral antigen's association with clinical worsening and longer time to discharge - highlights the need for targeted anti-viral trials in severe #COVID'. @AJRogers_ICU https://t.co/Y0GHFNMrAc
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 | Annals of Internal Medicine https://t.co/32rjTjf7Z3
Great cross-sectional study commented by @EricTopol in @AnnalsofIM. Investigation on the predictive role of plasmatic levels of #SARSCoV2 nucleocapsid antigen, an underrated (so far) prognostic marker in #COVID19. #IDTwitter https://t.co/Gp4Epxp609
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @Ron_Witteles: Congratulations to @StanfordMedRes Associate Program Director @AJRogers_ICU on leading this impactful study across 114 ce…
RT @Ron_Witteles: Congratulations to @StanfordMedRes Associate Program Director @AJRogers_ICU on leading this impactful study across 114 ce…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @KusumiEiji: 血清中のコロナウイルス抗原量(ウイルス量の代替指標)が多いほど、症状が重い https://t.co/zb66GSRGeX
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @Ron_Witteles: Congratulations to @StanfordMedRes Associate Program Director @AJRogers_ICU on leading this impactful study across 114 ce…
RT @Ron_Witteles: Congratulations to @StanfordMedRes Associate Program Director @AJRogers_ICU on leading this impactful study across 114 ce…
Congratulations to @StanfordMedRes Associate Program Director @AJRogers_ICU on leading this impactful study across 114 centers -- just published in @AnnalsofIM! Plasma levels of SARS-CoV-2 antigen strongly correlate with #COVID outcomes. @StanfordDeptMed
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @KazBowen: COVID19の患者さんの血中のN抗原の量が肺の重症化と相関しているというデータ。1ug/mlより上と下で明らかに肺障害の重症度が違う。もちろん因果関係はわからないが重症例と必ずしもウイルスゲノム量が比例しないのを考えると単にウイルス量が多いからとは…
RT @MamtaKJain: Excited to see our paper published. Important observation of Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @DrSamuelBrown: Such fantastic work from the TICO team, this effort led by Angela Rogers and so many others. Serum antigen levels are im…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @Snoopy_onmyway: >N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかなり規模の大きい研究。 はっきりとした関連があるように見える。 https://t.co/xuip4beKh2
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 | Annals of Internal Medicine https://t.co/ruHwh983ho
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
>N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかなり規模の大きい研究。 はっきりとした関連があるように見える。 https://t.co/xuip4beKh2
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
Elevated plasma antigen is highly associated with both severity of pulmonary illness and clinically important patient outcomes Multiple clinical and viral factors associated with plasma antigen level at presentation Potential role ongoing viral replication
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @Marc_Veld: The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 Again a hint of ongoing viral replication in the pathogenesis of SARS-CoV-2; Subgroup, also potential link with #longcovid https
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 | Annals of Internal Medicine https://t.co/xRSWfjnU0w
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
New article from #TICO/#ACTIV-3. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 | Annals of Internal Medicine. Well done Angela Roger’s and team https://t.co/imXVqFlhYk
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @EricTopol: Importance of the plasma #SARSCoV2 viral antigen (nucleocapsid) level as a predictor of acute adverse outcomes in hospitaliz…
RT @AJRogers_ICU: Thrilled to share this work from ACTIV3/TICO and >2000 pts, showing high plasma viral antigen's association with clinica…
RT @KazBowen: COVID19の患者さんの血中のN抗原の量が肺の重症化と相関しているというデータ。1ug/mlより上と下で明らかに肺障害の重症度が違う。もちろん因果関係はわからないが重症例と必ずしもウイルスゲノム量が比例しないのを考えると単にウイルス量が多いからとは…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @RutgerWalls: Today we publish this important manuscript in @AnnalsofIM led by Angela Rogers and the ACTIV-3/TICO: The Association of B…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…
RT @KazBowen: COVID19の患者さんの血中のN抗原の量が肺の重症化と相関しているというデータ。1ug/mlより上と下で明らかに肺障害の重症度が違う。もちろん因果関係はわからないが重症例と必ずしもウイルスゲノム量が比例しないのを考えると単にウイルス量が多いからとは…
RT @SukunaBikona7: 血中N抗原濃度1000ng/L以上はday5での肺の状態悪化するリスクが5.06倍となり、また入院期間が長期化した。 https://t.co/l8fG48jSpF N抗原、N蛋白が重症度に関連するという研究は以前もあったけれど、今回はかな…